Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Examining the Association Between Prenatal Antidepressant Exposure and the Incidence of Childhood Cardiometabolic Diseases

FY 2023-24

Summary
Supervisors: Dr. Sonia Grandi, University of Toronto, The Hospital for Sick Children; Dr. Hilary Brown, University of Toronto, Women's College Hospital Depression and anxiety are common health conditions in pregnancy. Untreated depression or anxiety during pregnancy can negatively impact both the mother and child. Therefore, treatment in pregnancy with antidepressants is often needed to prevent adverse outcomes. However, antidepressant use has been linked with cardiometabolic side effects (e.g., changes in blood sugar, blood pressure, lipid levels, and weight) in adults (e.g., pregnant women) and children taking antidepressants. These cardiometabolic effects can cause lasting health issues and burden patients, families, and the healthcare system. Despite this, information on antidepressant use in pregnancy and the risk of later childhood cardiometabolic diseases in offspring is limited. Therefore, this study aims to identify the risk of cardiometabolic diseases (e.g., diabetes, high blood pressure) among children born to mothers who used antidepressants during pregnancy. Using Danish health registry data, I will compare the risk of cardiometabolic diseases among children exposed versus unexposed to antidepressants during their mother's pregnancy. With advanced statistical methods, I will examine the risk of childhood cardiometabolic diseases associated with antidepressant use during pregnancy, considering other factors that may influence this relationship (i.e., mother's depression status; timing, dose, or type of antidepressant; and child sex). I will then identify possible pathways between antidepressant use in pregnancy and cardiometabolic diseases among exposed children. This study will improve our understanding of the link between antidepressant use in pregnancy and the risk of childhood cardiometabolic diseases to help clinicians, public health leaders, policymakers, and patients make informed decisions about antidepressant medication use in pregnancy.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
495742
Name
Tailor Lauren S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Examining the Association Between Prenatal Antidepressant Exposure and the Incidence of Childhood Cardiometabolic Diseases
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Antidepressants; Biostatistics; Cardiometabolic Diseases; Drug Safety; Mental Health; Paediatric Health; Perinatal Health; Pharmacoepidemiology; Population Health; Women'S Health
Abstract
Supervisors: Dr. Sonia Grandi, University of Toronto, The Hospital for Sick Children; Dr. Hilary Brown, University of Toronto, Women's College Hospital Depression and anxiety are common health conditions in pregnancy. Untreated depression or anxiety during pregnancy can negatively impact both the mother and child. Therefore, treatment in pregnancy with antidepressants is often needed to prevent adverse outcomes. However, antidepressant use has been linked with cardiometabolic side effects (e.g., changes in blood sugar, blood pressure, lipid levels, and weight) in adults (e.g., pregnant women) and children taking antidepressants. These cardiometabolic effects can cause lasting health issues and burden patients, families, and the healthcare system. Despite this, information on antidepressant use in pregnancy and the risk of later childhood cardiometabolic diseases in offspring is limited. Therefore, this study aims to identify the risk of cardiometabolic diseases (e.g., diabetes, high blood pressure) among children born to mothers who used antidepressants during pregnancy. Using Danish health registry data, I will compare the risk of cardiometabolic diseases among children exposed versus unexposed to antidepressants during their mother's pregnancy. With advanced statistical methods, I will examine the risk of childhood cardiometabolic diseases associated with antidepressant use during pregnancy, considering other factors that may influence this relationship (i.e., mother's depression status; timing, dose, or type of antidepressant; and child sex). I will then identify possible pathways between antidepressant use in pregnancy and cardiometabolic diseases among exposed children. This study will improve our understanding of the link between antidepressant use in pregnancy and the risk of childhood cardiometabolic diseases to help clinicians, public health leaders, policymakers, and patients make informed decisions about antidepressant medication use in pregnancy.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tailor, Lauren S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
University of Toronto - $150,000 Grant (2023-24) | Canada Spends